Search for Clinical Trial Results

Sponsored By

Nasopharyngeal Neoplasms - 25 Studies Found

Status Study
Completed Study Name: Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy
Condition: Nasopharyngeal Neoplasms
Date: 2008-02-25
Interventions: Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen
Completed Study Name: Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Neoplasms
Date: 2008-09-04
Interventions: Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni
Not yet recruiting Study Name: Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2017-03-16
Interventions:
  • Other: adverse events using patient-reported outcomes version of common term
Recruiting Study Name: A Trial of Endostar in Patients With Carcinoma of the Head and Neck
Condition: Nasopharyngeal Neoplasms
Date: 2016-08-12
Interventions: Drug: Endostar The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receiv
Recruiting Study Name: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
Condition:
Date: 2023-09-22
Enrolling by invitation Study Name: A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2015-04-07
Interventions:
  • Drug: endostar Other Name: Hum
Completed Study Name: The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Neoplasms
Date: 2013-02-21
Interventions:
  • Drug: Cisplatin induction: Cis
Completed Study Name: Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Condition: Nasopharyngeal Neoplasms
Date: 2007-12-18
Interventions:
  • Procedure: Conventional Radiotherapy
  • Proce
Completed Study Name: Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2007-02-16
Interventions:
  • Drug: Gemcitabine 1000mg/m
Completed Study Name: Taxotere + Cisplatin in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2007-02-16
Interventions:
  • Drug: Docetaxel 75 mg/m²
Next >>>